Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Clarivate Names World's Leading Journals with the 2022 Journal Citation Reports

This image opens in the lightbox

News provided by

Clarivate Plc

28 Jun, 2022, 09:00 GMT

Share this article

Share toX

Share this article

Share toX

Continued increase in citation impact for journals publishing COVID-19 research

LONDON, June 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the 2022 update to its annual Journal Citation Reports (JCR)™. The annual JCR release enables the research community to evaluate the world's high-quality academic journals using a range of indicators, descriptive data and visualizations. The reports are used extensively by academic publishers across the globe to understand the scholarly impact of their journals relative to their field and promote them to the research community. 

The JCR is based on 2021 data compiled from the Web of Science Core Collection™, the leading collection of quality journals, books and conference proceedings in the world's largest publisher-neutral global citation database. Publications are evaluated by a global team of in-house editors at Clarivate using rigorous selection criteria. The data from selected content are then carefully curated to ensure accuracy in the JCR metrics, together with a wide body of descriptive data. These insights enable researchers, publishers, editors, librarians and funders to explore the key drivers of a journal's value for diverse audiences.

COVID-19 continues to influence every aspect of scholarly publishing, just as it has affected every aspect of society 

Dr Nandita Quaderi, Editor-in-Chief & Vice President Editorial, Web of Science said: "Through the carefully selected and curated data within the Journal Citation Reports, we can fully appreciate and understand the enormous impact of the academic community's rapid response to the COVID-19 pandemic.

"As researchers explored the origins, spread and ramifications of the virus, working at speed to create new therapies and vaccines, we see this reflected in the trusted insights contained in the annual JCR.  The effects of this pandemic will continue to be seen in the literature and citation impact for decades, particularly under the lens of the UN's Sustainable Development Goal 3 on Health and Wellbeing. We are proud to support the research community and the UN SDGs with expertly curated data that informs decisions and helps them accelerate the pace of innovation."  

This year's release sees continued notable increases in citation impact for journals in the fields of general medicine, critical care, public health, infectious diseases, immunology and basic biomedical sciences

  • This year The Lancet's Journal Impact Factor™ (JIF) of 202.731 has moved it to the #1 position in the general & internal medicine category, overtaking the New England Journal of Medicine, which has been the top-ranked title in that category since the first release of the JCR 45 years ago. Of the 10 articles with the highest citation count in 2021, three appeared in The Lancet. All three are directly related to the characterization and treatment of COVID-19.
  • This year Nature earns the distinction of being the first ever journal to accumulate more than one million total citations in one year. Nature published 16 items with over 500 JIF citations – of which 12 items were COVID-19 related.
  • Seven journals had JIFs of more than 100 for the first time, all of which published high quantities of COVID-19 related research. These are the Journal of the American Medical Association, The Lancet, Lancet Respiratory Medicine, Nature Reviews Drug Discovery, Nature Reviews Immunology, Nature Reviews Molecular Cell Biology and the New England Journal of Medicine.

Upholding research integrity and a new type of citation distortion

To support objectivity in journal selection and the integrity of the reports, Clarivate has suppressed three journals from the JCR (without presumption or accusation of wrong doing), representing 0.01% of the journals listed. Clarivate monitors and excludes journals that demonstrate anomalous citation behavior including where there is evidence of excessive journal self-citation and/or citation stacking. The methodology and parameters for the effect of journal self-citation on JCR metrics were updated in 2020 to better account for discipline norms. The suppression of a journal from the JCR does not equate to a de-listing from the Web of Science Core Collection.  

In addition, this year the editorial integrity team at Clarivate identified a new type of anomalous citation behavior: self stacking. This is where the journal contains one or more documents with citations that are highly concentrated to the JIF numerator of the title itself.  This is the first year we have formally defined the criteria for self-stacking suppression, and as such we have made the decision to issue a warning to six journals rather than suppress the journal's JIF. Going forward, continued journal self-stacking will result in suppression of JIF.  

Clarivate continuously reviews content with the goal of developing additional screening for distortions of the JIF.  

Key facts from the 2021 data:

  • The Journal Citation Reports contains more than 21,000 journals, from 254 research categories and 114 countries. This includes:
    • 12,800 science journals
    • 6,600 social science journals
    • 3,000 arts and humanities journals
  • Almost 13,000 journals have at least one gold open access publication
  • More than 5,300 journals publish all of their content via open access
  • 192 journals received a Journal Impact Factor for the first time

Each journal profile in the JCR provides a rich array of journal intelligence metrics and allows users to filter by category and rank. These include:  

  • The Journal Citation Indicator, which represents the average category-normalized citation impact for papers published in the prior three-year period. All journals in the JCR are eligible to receive this metric as of 2021;
  • The Immediacy Index, which measures how frequently the journal's content is cited within the same year as publication;
  • The journal's rank in category, determined by Journal Impact Factor, expressed as a percentile;
  • Cited half-life, which is the median age, in years, of items in the journal that were cited during the JCR year; and
  • The Journal Impact Factor, which is given to journals in SCIE and SSCI, and which scales the citations received to recent content by a measure of the size of the journal's scholarly output.

In addition, the Journal Citation Reports include descriptive data such as open access content, top contributing institutions and regions.

For a more detailed explanation of this year's release, please see our blog.  

Visit the Journal Citation Reports website to explore all available data, metrics and analysis. You can find more information including our suppression policy in the Journal Citation Reports Reference Guide.

Follow us on Twitter via @ClarivateAG #JCR2022.  

About Clarivate

Clarivate™ is a global leader in providing solutions to accelerate the pace of innovation. Our bold mission is to help customers solve some of the world's most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of Academia & Government, Life Sciences & Healthcare, Professional Services and Consumer Goods, Manufacturing & Technology. We help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit clarivate.com.

Media Contact 
Amy Bourke-Waite
External Communications Director (Academia and Government)
newsroom@clarivate.com  

Logo - https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg

Modal title

Also from this source

Clarivate Unveils the 2025 Journal Citation Reports

Clarivate Unveils the 2025 Journal Citation Reports

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the 2025 update to the Journal Citation Reports...

Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology

Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of a new Companies to Watch report,...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Publishing & Information Services

Publishing & Information Services

Data Analytics

Data Analytics

Data Analytics

Data Analytics

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.